153 related articles for article (PubMed ID: 15966703)
1. Endoglin (CD105) expression in head and neck basaloid squamous cell carcinoma.
Marioni G; Gaio E; Giacomelli L; Marchese-Ragona R; Staffieri C; Staffieri A; Marino F
Acta Otolaryngol; 2005 Mar; 125(3):307-11. PubMed ID: 15966703
[TBL] [Abstract][Full Text] [Related]
2. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
Marioni G; Ottaviano G; Marchese-Ragona R; Giacomelli L; Bertolin A; Zanon D; Marino F; Staffieri A
Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
[TBL] [Abstract][Full Text] [Related]
3. Angiogenin expression in head and neck basaloid and conventional squamous cell carcinoma: a site- and stage-matched comparison.
Marioni G; Staffieri A; Savastano M; Marino F; Giacomelli L; Lionello M; Casotto F; de Filippis C; Blandamura S
J Oral Pathol Med; 2011 Jan; 40(1):55-60. PubMed ID: 20923443
[TBL] [Abstract][Full Text] [Related]
4. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma.
Marioni G; D'Alessandro E; Giacomelli L; Staffieri A
J Oral Pathol Med; 2010 May; 39(5):361-7. PubMed ID: 20537053
[TBL] [Abstract][Full Text] [Related]
5. Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.
Kyzas PA; Agnantis NJ; Stefanou D
Virchows Arch; 2006 Jun; 448(6):768-75. PubMed ID: 16612622
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) expression in squamous cell carcinoma of the oral cavity.
Schimming R; Marmé D
Head Neck; 2002 Feb; 24(2):151-6. PubMed ID: 11891945
[TBL] [Abstract][Full Text] [Related]
7. Microvessel density in head and neck squamous cell carcinoma.
Szafarowski T; Sierdzinski J; Szczepanski MJ; Whiteside TL; Ludwig N; Krzeski A
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1845-1851. PubMed ID: 29748768
[TBL] [Abstract][Full Text] [Related]
8. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
[TBL] [Abstract][Full Text] [Related]
9. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas.
Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA
APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
[TBL] [Abstract][Full Text] [Related]
11. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status.
Begum S; Westra WH
Am J Surg Pathol; 2008 Jul; 32(7):1044-50. PubMed ID: 18496144
[TBL] [Abstract][Full Text] [Related]
12. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.
Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011
[TBL] [Abstract][Full Text] [Related]
13. Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinoma.
Marioni G; Marino F; Giacomelli L; Staffieri C; Mariuzzi ML; Violino E; De Filippis C
Acta Otolaryngol; 2006 Jun; 126(6):633-9. PubMed ID: 16720449
[TBL] [Abstract][Full Text] [Related]
14. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma.
Marioni G; Ottaviano G; Giacomelli L; Staffieri C; Casarotti-Todeschini S; Bonandini E; Staffieri A; Blandamura S
Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866
[TBL] [Abstract][Full Text] [Related]
15. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
Behrem S; Zarkovic K; Eskinja N; Jonjic N
Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
[TBL] [Abstract][Full Text] [Related]
16. BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.
Linskey KR; Gimbel DC; Zukerberg LR; Duncan LM; Sadow PM; Nazarian RM
Arch Pathol Lab Med; 2013 Nov; 137(11):1591-8. PubMed ID: 24168496
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic study on basaloid squamous cell carcinoma in the oral and maxillofacial region.
Yu GY; Gao Y; Peng X; Chen Y; Zhao FY; Wu MJ
Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1003-8. PubMed ID: 18632253
[TBL] [Abstract][Full Text] [Related]
18. Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival.
Marioni G; Marino F; Blandamura S; D'Alessandro E; Giacomelli L; Guzzardo V; Lionello M; De Filippis C; Staffieri A
Histopathology; 2010 Oct; 57(4):535-43. PubMed ID: 20955379
[TBL] [Abstract][Full Text] [Related]
19. Basaloid in contrast to nonbasaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes.
Poetsch M; Lorenz G; Bankau A; Kleist B
Head Neck; 2003 Nov; 25(11):904-10. PubMed ID: 14603450
[TBL] [Abstract][Full Text] [Related]
20. Neoangiogenesis in temporal bone carcinoma: the prognostic role of CD105.
Marioni G; Nucci R; Marino F; Giacomelli L; Rugge M; Pareschi R; Martini A
Otol Neurotol; 2012 Jul; 33(5):843-8. PubMed ID: 22643443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]